Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals (LGND) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• LGND last traded at $311.34, -3.54% on the day.
• Ligand Pharmaceuticals: market cap $6.43B, P/E 120.2, revenue $253.83M over the last four quarters.
• Over the past year LGND returned 66.44%; year to date 64.67%.

Updated 2026-11-02 19:51 UTC